Wait, What? Iron and Sulfur Become a Working Part of Proteins
Iron–sulfur clusters are tiny inorganic cofactors built from iron and sulfur atoms, commonly as [2Fe–2S] or [4Fe–4S] structures. They sit inside proteins and make difficult chemistry possible: electron transfer, enzyme catalysis, DNA replication, DNA repair, ribosome function and iron sensing.
The surprising part is that cells do not simply let iron and sulfide meet randomly. Free iron and sulfur chemistry can be dangerous. Instead, cells assemble clusters on dedicated protein scaffolds, transfer them through controlled relay systems and install them into selected target proteins.
Iron–sulfur biology is not “iron inside proteins”. It is a managed assembly-and-delivery system.
The One-Sentence Answer
Learn human iron–sulfur cluster biogenesis by following sulfur from cysteine and iron into the mitochondrial NFS1–ISCU assembly complex, then trace how newly built clusters are transferred to mitochondrial, cytosolic and nuclear proteins and how failure of that relay changes metabolism, DNA maintenance and iron homeostasis.
Stage 1: Start With the Jobs
Fe–S proteins occur throughout the cell. Examples include respiratory-chain proteins, aconitase, lipoate synthase, DNA helicases, primase-related proteins and the ribosome-recycling factor ABCE1. The same cofactor family supports many different biochemical jobs.
Stage 2: Why Build the Cluster Before Installing It?
Reactive iron and sulfur species can damage cells if uncontrolled. Dedicated assembly proteins hold the components in a protected molecular environment. The cluster is built first, then transferred to an apo-protein that lacks its cofactor.
Stage 3: Human Fe–S Biogenesis Begins in Mitochondria
The mitochondrial iron–sulfur cluster assembly system, often called the ISC machinery, is central to human Fe–S protein maturation. It supports mitochondrial targets directly and also provides essential input for cytosolic and nuclear Fe–S assembly.
Stage 4: NFS1 Extracts Sulfur From Cysteine
NFS1 is a cysteine desulfurase. With partner proteins including ISD11/LYRM4 and mitochondrial acyl-carrier protein, it converts cysteine sulfur into a form that can be delivered toward cluster synthesis.
Stage 5: ISCU Is the Early Scaffold
ISCU provides a temporary binding platform on which a nascent cluster can form. The scaffold solves an important problem: the cell can assemble the cofactor without exposing the whole cytoplasm or mitochondrial matrix to uncontrolled inorganic chemistry.
Stage 6: Frataxin Controls the Assembly Reaction
Frataxin, encoded by FXN, interacts with the core ISC complex and promotes efficient sulfur transfer and cluster formation under appropriate conditions. Loss of frataxin disrupts Fe–S protein maturation and is central to Friedreich ataxia.
Stage 7: Electrons Are Required Too
Cluster formation is a redox process. Ferredoxin-related proteins, particularly FDX2 in human mitochondria, contribute reducing equivalents to the assembly system. This connects Fe–S synthesis to the cell’s broader redox economy.
Stage 8: The First Cluster Is Not Always the Final Cluster
Early ISC machinery commonly generates [2Fe–2S] species. Additional proteins including ISCA1, ISCA2 and IBA57 participate in maturation of selected [4Fe–4S] clusters. Fe–S biogenesis is therefore staged rather than one universal reaction.
Stage 9: Chaperones Help Release and Transfer the Cluster
HSPA9/HSC20-related chaperone systems help move clusters away from ISCU and toward recipient proteins or downstream transfer factors. The cluster must leave the scaffold without being lost or misdelivered.
Stage 10: Specific Recipients Need Specific Delivery Factors
Proteins such as NFU1, BOLA3 and GLRX5 help route Fe–S clusters to different client proteins. The system is not simply a shared pool in which every apo-protein grabs a cluster at random.
Stage 11: Respiratory Complexes Depend on Fe–S Delivery
Complex I contains multiple Fe–S centres that relay electrons from NADH toward ubiquinone. Complex II contains Fe–S centres as well. Defective cluster installation can therefore compromise mitochondrial respiration even when mitochondrial DNA and membrane structure remain intact.
Connect this with Mitochondria and Mitochondrial Dynamics.
Stage 12: Aconitase Shows How One Cluster Can Change Function
Mitochondrial aconitase uses an Fe–S cluster for citric-acid-cycle chemistry. Cytosolic aconitase, also known as IRP1, demonstrates an even more striking principle: when its cluster is present it behaves as an enzyme; when the cluster is lost, the same protein can bind iron-responsive RNA elements.
Stage 13: IRP1 Links Fe–S Status to Cellular Iron Regulation
Low Fe–S availability converts IRP1 toward an RNA-binding state. That can change expression of ferritin, transferrin receptor and other iron-handling proteins. A cofactor-assembly pathway therefore helps regulate the supply of its own raw material.
Stage 14: Mitochondria Support Cytosolic Fe–S Assembly
Cytosolic and nuclear Fe–S proteins are matured by the CIA, or cytosolic iron–sulfur assembly, machinery. Mitochondrial ISC function is still required upstream. ABCB7 and glutathione-related chemistry participate in exporting a sulfur-containing signal or intermediate that supports this pathway, although the exact exported species remains an active mechanistic question.
Stage 15: The CIA Machinery Builds a Second Delivery Network
CIA components generate and transfer Fe–S clusters to cytosolic and nuclear targets. Proteins including CIAO1, CIAO2B and MMS19 help form targeting complexes for selected recipients.
Stage 16: DNA Replication Uses Fe–S Proteins
Several eukaryotic DNA polymerase and primase components depend on Fe–S cofactors for correct assembly or function. This means Fe–S deficiency can become a genome-maintenance problem, not only an energy-metabolism problem.
Stage 17: DNA Repair Helicases Use Fe–S Cofactors
Helicases such as XPD, FANCJ, DDX11 and RTEL1 contain Fe–S domains that support nucleic-acid processing. These proteins participate in nucleotide-excision repair, interstrand-crosslink responses, cohesion-related processes and telomere maintenance.
Stage 18: ABCE1 Connects Fe–S Biology to Translation
ABCE1 contains Fe–S clusters and helps recycle ribosomes after translation termination. Fe–S biogenesis therefore reaches from mitochondrial metabolism to the protein-synthesis machinery.
Stage 19: Radical-SAM Enzymes Use Fe–S Chemistry Differently
Some enzymes use [4Fe–4S] clusters to generate radical intermediates. Lipoate synthase is one example. Its activity is necessary for producing lipoate used by major mitochondrial enzyme complexes.
Stage 20: Fe–S Biogenesis and Heme Synthesis Intersect
Human ferrochelatase, the terminal enzyme of heme synthesis, itself contains a [2Fe–2S] cluster. Fe–S state can therefore affect another major iron-dependent cofactor pathway.
Stage 21: Friedreich Ataxia Reveals the Frataxin Layer
Reduced frataxin impairs Fe–S protein maturation, alters mitochondrial iron handling and produces progressive tissue dysfunction. High-energy tissues are especially vulnerable, but the disease cannot be reduced to “not enough ATP”; redox, iron and genome effects interact.
Stage 22: ABCB7 and Other Transfer Defects Reveal the Export Layer
Mutations affecting ABCB7 or downstream transfer proteins can disrupt particular Fe–S clients and produce characteristic neurological, haematological or metabolic phenotypes. The pattern of disease helps identify where the relay failed.
Stage 23: Copper Can Interfere With Fe–S Biology
Excess copper can destabilise Fe–S proteins or interfere with their biogenesis. This creates an important connection between metal-homeostasis systems: the cell must control not only how much metal is present, but where each metal is allowed to react.
Stage 24: Oxygen and Reactive Species Matter
Fe–S clusters can be sensitive to oxidation. Oxidative stress can damage existing clusters and increase demand for repair or replacement. But “ROS destroys Fe–S clusters” is too simple; sensitivity depends on cluster type, protein environment, compartment and exposure.
Connect this with Redox Biology and Oxidative Stress.
Stage 25: Current 2025–2026 Research Extends Fe–S Function Beyond the Classical Map
Recent work continues to identify Fe–S-dependent proteins and disease dependencies. A 2026 Nature Communications study reported that mitochondrial CLPX can acquire an Fe–S cluster and linked cluster supply to mitochondrial proteostasis under cysteine limitation. A 2026 review of Fe–S cofactors in nucleic-acid metabolism further consolidates the idea that these cofactors are deeply embedded in genome biology, not just respiration.
Stage 26: Measurement Must Separate Cluster Presence From Protein Amount
A protein can be present but lack its cofactor. Western blotting alone cannot prove Fe–S loading. Researchers combine enzyme activity, spectroscopy, isotope tracing, metalloproteomics, genetics and structural methods to distinguish abundance from functional cluster occupancy.
Stage 27: Iron Measurements Need Compartment Context
Total-cell iron can remain unchanged while mitochondrial iron rises and cytosolic usable iron falls. Compartment-resolved measurements are therefore more informative than a single bulk iron value.
Stage 28: Structure Explains Why Assembly Order Matters
Cryo-EM, crystallography and biochemical reconstruction reveal how NFS1, ISCU, frataxin and partner proteins rearrange during sulfur transfer and cluster formation. Structural biology turns a list of factors into a mechanistic sequence.
Stage 29: Professional Fe–S Biology Is a Supply-Chain Problem
The mature question is not merely “Does this protein need iron?” It is:
Which cluster type does this protein require, where was that cluster assembled, which transfer factors delivered it, and which downstream function fails if delivery is incomplete?
Misconceptions Worth Hunting
- Fe–S clusters form by random iron and sulfur collision.
- Fe–S proteins are only respiratory-chain proteins.
- Mitochondrial Fe–S assembly matters only inside mitochondria.
- Protein abundance proves cluster loading.
- Every Fe–S protein receives its cofactor directly from ISCU.
- Frataxin is simply an iron-storage protein.
- All Fe–S clusters are chemically identical.
- A cell with normal total iron must have normal Fe–S biology.
Transfer Check
Reduce NFS1 activity. Would only complex I be affected? No. Multiple mitochondrial and extra-mitochondrial Fe–S proteins can be affected.
Measure normal abundance of an Fe–S enzyme but low catalytic activity. Can you conclude the gene is expressed normally and therefore the Fe–S pathway is fine? No. Cofactor loading may be defective.
Observe mitochondrial iron accumulation together with cytosolic iron-starvation signalling. Is that contradictory? No. Iron can be trapped in one compartment while functionally unavailable in another.
How We Know the Learning Has Held
- Explain why Fe–S clusters require controlled assembly.
- Trace sulfur through NFS1 and ISCU.
- Explain frataxin and ferredoxin contributions.
- Distinguish early [2Fe–2S] assembly from later [4Fe–4S] maturation.
- Explain mitochondrial and CIA pathways.
- Connect Fe–S cofactors to respiration, DNA metabolism, translation and iron regulation.
- Explain why Friedreich ataxia is a systems-level Fe–S disorder.
- Distinguish protein abundance from cofactor occupancy.
Model Limits
The exact chemical species exported from mitochondria to support cytosolic Fe–S assembly remains an active research question. Different Fe–S clients use different transfer proteins. Disease phenotypes reflect tissue-specific demand and secondary metabolic effects. In-vitro reconstitution can simplify the crowded environment of a living cell.
A strong model keeps cluster type + assembly site + transfer route + target protein + functional consequence visible together.
Research Foundations
- Current human ISC/CIA biogenesis literature and structural studies of NFS1–ISCU–frataxin assembly.
- 2025–2026 work on mitochondrial iron handling and Fe–S dependencies in disease.
- 2026 work extending Fe–S biology into mitochondrial proteostasis and nucleic-acid metabolism.
- Classical genetic and biochemical evidence from Friedreich ataxia and Fe–S transfer disorders.
The Quiet Ending
The beginner asks, “Which proteins contain iron?”
The developing biologist asks, “How is an Fe–S cluster assembled?”
And the professional asks:
Which assembly and delivery step explains why this specific Fe–S-dependent function failed even though the protein itself is still present?
